Business Context and Reporting Period
Company: Innoviz Technologies Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Second Quarter 2025
Filing Date: August 13, 2025
Context: This filing incorporates by reference a press release titled "Innoviz Reports Second Quarter 2025 Results" (Exhibit 99.1). The filing serves to update U.S. investors on the company's financial performance for the quarter ended June 30, 2025.
Key Financial Metrics
The provided text is a cover sheet for Form 6-K and does not contain the specific numerical data from the attached press release. Consequently, the following metrics are not available in the source text:
- Revenue: Not provided in the filing text.
- Profit/Loss: Not provided in the filing text.
- Cash Flow: Not provided in the filing text.
- Margins: Not provided in the filing text.
- Debt and Liquidity: Not provided in the filing text.
Note: The filing states that financial information is contained in the condensed consolidated statements within Exhibit 99.1, but the content of that exhibit is not included in the input provided.
Material Changes
The filing text does not provide specific data to compare current period results against the prior comparable period. No material changes in revenue, expenses, or operational metrics can be summarized from the provided cover sheet alone.
Guidance, Outlook, and Risks
The provided text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. These elements are expected to be detailed in the attached press release (Exhibit 99.1), which is referenced but not included in the input content.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual Q2 2025 revenue and net loss figures.
- Verify cash burn rate and remaining liquidity runway as disclosed in the full press release.
- Check for updates on major customer contracts or production milestones mentioned in the full report.
- Confirm any changes in the company's full-year 2025 financial guidance.
- Assess any new risk factors or legal contingencies disclosed in the detailed financial statements.